| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.12 | 0.008 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.009 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.01 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |